Available Until 1/31/2023

Intensive Studies for Recertification: Pediatric Pharmacy (Cert # L229097)

ACPE Numbers: Various – see listing below
Pre-Sale Date: 01/04/2022
Content Release Date: 02/02/2022
Expiration Date: 01/31/2023
Activity Type: Application-based
CE Credits: 4.25 (BPS and ACPE) contact hours
Activity Fee: $100 (ASHP member); $150 (non-member)

Activity Overview

The Intensive Study Package is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues in pediatric pharmacy. 

The Pediatric Pharmacy Intensive Study Recertification Package consists of 3 activities (see table below) and provides up to 4.25 contact hours of continuing pharmacy education and/or recertification credit.   

These activities are part of the ASHP professional development program for BCPPS recertification approved by the BPS.  For pharmacists who maintain more than one certification, one of the activities is approved for multiple specialties (see table below).

These activities were presented as part of the 2021 Virtual Midyear Clinical Meeting. Learners who claimed ACPE credit for these activities as part of that meeting should not claim ACPE credit again.

 

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:

  • Asthma
  • Cystic Fibrosis
  • Septic Shock

Recertification Credit

Board certified pharmacists are eligible to receive up to 4.25 contact hours of recertification credit for completing this package. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Learning Activity

ACPE Number

Contact Hours (ACPE & BPS)

Recertification Assessment

Breathe Easy: An Update in Cystic Fibrosis Care (BCPPS)

0204-0000-21-238-H01-P

1.00

76%

Just Breathe: Asthma Management Update for Pediatric Patients (BCPPS)

0204-0000-21-300-H01-P

1.75

73%

Fluid Resuscitation Controversies in Adult and Pediatric Septic Shock – Does One Size Fit All? (BCPPS, BCCCP, BCPS)

0204-0000-21-246-H01-P

1.50

73%

Breathe Easy: An Update in Cystic Fibrosis Care
0204-0000-21-238-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Given a patient case, choose the indicated cystic fibrosis transmembrane conductance regulator (CFTR) modulator based on patient demographics and cystic fibrosis (CF) genetics.
  • Given a patient case, recommend adjustments in cystic fibrosis treatment in special populations (e.g., pregnancy, lactation, and postlung transplant), as well as for drug-drug interactions.
  • Given a patient case, develop a monitoring plan for newly initiated CFTR modulator therapy. 

This activity is approved for Board Certified Pediatric Pharmacy Specialists (BCPPS) recertification credit. 

Just Breathe: Asthma Management Update for Pediatric Patients
0204-0000-21-300-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Compare the National Asthma Education and Prevention Program (NAEPP) and the Global Initiative for Asthma (GINA) treatment recommendations for pediatric patients with asthma.
  • Develop a treatment plan for a pediatric patient with asthma.
  • Select an appropriate long-acting muscarinic antagonist or biologic for the management of asthma in a pediatric patient.
  • Differentiate between various chronic pediatric asthma medication formulations. 

This activity is approved for Board Certified Pediatric Pharmacy Specialists (BCPPS) recertification credit. 

Fluid Resuscitation Controversies in Adult and Pediatric Septic Shock – Does One Size Fit All?
0204-0000-21-246-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Analyze recommendations for the initial fluid bolus dose for adult patients with septic shock.
  • Select an appropriate fluid bolus dose for a pediatric patient with septic shock.
  • Recommend the most appropriate type of fluid for an adult or pediatric patient with septic shock.
  • Evaluate strategies for assessing fluid responsiveness in adults.
  • Recognize criteria for reassessment of fluid management in children. 

This activity is approved for Board Certified Critical Care Pharmacists (BCCCP), Board Certified Pediatric Pharmacy Specialists (BCPPS), and Board Certified Pharmacotherapy Specialists (BCPS) recertification credit.

Faculty bios

Jenn Dannelley, Pharm.D.
Clinical Pharmacist
Pediatric Cystic Fibrosis Program Coordinator
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 

Lea S. Eiland, Pharm.D., BCPS, BCPPS, FASHP, FPPA
Clinical Professor and Associate Department Head of Pharmacy Practice
Auburn University Harrison School of Pharmacy
Auburn, Alabama 

Pete Johnson, Pharm.D., BCPS, BCPPS, FPPA, FCCM, FASHP
Professor—University of Oklahoma College of Pharmacy
CICU Pediatric Clinical Specialist—Oklahoma Children’s Hospital at OU Health
Oklahoma City, Oklahoma 

Nicole E. Omecene, Pharm.D., BCPPS
Assistant Professor in Pediatrics
Department of Pharmacotherapy & Outcomes Science
Virginia Commonwealth University School of Pharmacy
Richmond, Virginia 

Heather Torbic, Pharm.D., BCPS, BCCCP
Medical ICU Clinical Specialist—Cleveland Clinic
Cleveland, Ohio

Holly L. Byrnes, Pharm D., BCPS
Susan R. Dombrowski, M.S., R.Ph.
Kristi Hofer, Pharm.D.
Paul M. Szumita, Pharm.D., BCCCP, BCPS, FASHP, FCCM
Jennifer Thackray, Pharm.D., BCPPS, BCPS*
Jamie Miller, Pharm.D., BCPPS, BCPS, FPPAG*
Pete Johnson, Pharm.D., BCPS, BCPPS, FPPA, FCCM, FASHP*

*Content Matter Experts

Hakeem Abayomi, B.S., Pharm.D., BCPS, BCPPS, BCIDP
Lawrence Alejandro, Pharm.D., BCPPS
John Austin, Pharm.D., BCPS, BCCCP
Vicki Basalyga, Pharm.D., BCPS, BCPPS
Jeff Butler, Pharm.D., BCPPS
Jesse Cramer, Pharm.D., BCPPS
Melissa Cwiklinski, Pharm.D., BCPPS
Mackenzie DeVine, Pharm.D., BCPPS
Sonia Everhart, Pharm.D., BCPS, BCCCP, FCCM
Alexandra Fife, Pharm.D.., BCPPS
Kristen Finical, BGS, Pharm.D., BCPPS
Jessica Frye, Pharm.D., BCPPS
Christina Hellauer, Pharm.D., BCPPS
Brendan Homanick, Pharm.D., BCPPS
Eok Jun, Pharm.D., BCPPS
Nancy Koo, Pharm.D., BCPPS
Dalton Kuebel, Pharm.D., BCCCP
Biljana Lanier, BS.Pharm., BCPPS
Thomas Laudone, Pharm.D., BCPPS
Rebecca Lee, Pharm.D.
Ann Lieb, Pharm.D., BCPPS
Julie Miller, Pharm.D., BCPPS
Haley Morrissey, Pharm.D., BCCCP
Lucas Orth, Pharm.D., BCPPS
Kajal K Patel, Pharm.D., BCPS, BCCCP
Nicole Rudawsky, Pharm.D., BCPS
Dimitrios Savva, Pharm.D., BCPPS
Beth Sawrey, Pharm.D., BCPPS
Anna Simmont, Pharm.D., BCPS, BCPPS
Bridger Singer, Pharm.D., BCPS, BCCCP
Melanie Sisco, Pharm.D., BCPS, BCCCP
Keyosha Smart, Pharm.D., BCPPS
Sadie Stone, Pharm.D., BCPPS
Maria Stubbs, BS.Pharm., BCPS-AQ Cardiology, BCCCP
Steve Tran, Pharm.D., BCPS, BCPPS
Julie Tremblay, BCPPS
Shelby Warring, Pharm.D., BCPPS
Ashley Wu, Pharm.D., BCPPS

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content. 

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

Activities which can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations.  Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

These activities were developed by ASHP.